TY - JOUR
T1 - CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP
AU - Nishiyama, Kanako
AU - Maekawa, Masashi
AU - Nakagita, Tomoya
AU - Nakayama, Jun
AU - Kiyoi, Takeshi
AU - Chosei, Mami
AU - Murakami, Akari
AU - Kamei, Yoshiaki
AU - Takeda, Hiroyuki
AU - Takada, Yasutsugu
AU - Higashiyama, Shigeki
N1 - Funding Information:
We thank Ms. Ai Yanase, Ms Yoko Ikeda, Ms Mari Makimoto (Ehime University) for providing their technical assistance, Drs Igor Kovacevic (Martin Luther University Halle-Wittenberg), and Peter L Hordijk (Amsterdam University) for providing their useful information, Dr Masaaki Sawa (Carna Biosciences, Inc) for providing reagents. The establishment and screen of the protein arrays used in this study were partially supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). Some of the cDNA resources were provided by a collaboration with the Kazusa DNA Research Institute. This work was supported by JSPS KAKENHI grant Number 19K18030 to K Nishiyama, Japan Foundation for Applied Enzymology, Research Grant of the Princess Takamatsu Cancer Research Fund, The Research Foundation for Pharmaceutical Sciences to M Maekawa, JSPS KAKENHI Grant Number 19K18029 to A Murakami, JSPS KAKENHI grant Number 21H02763 to S Higa-shiyama, Takeda Science Foundation to Proteo-Science Center.
Publisher Copyright:
© 2021 Nishiyama et al.
PY - 2021/6
Y1 - 2021/6
N2 - Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3/KCTD10 E3 complex, enabled CNKSR1 to interact with PTPRH at the plasma membrane resulting in inactivation of EGFR phosphatase activity. Depletion of CUL3 or KCTD10 led to the accumulation of RhoB-GTP at the plasma membrane followed by its interaction with CNKSR1, which released activated PTPRH from CNKSR1. This study suggests a mechanism of PTPRH activation through the exclusive binding of RhoB-GTP to CNKSR1.
AB - Epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation drives HER2-positive breast cancer cell proliferation. Enforced activation of phosphatases for those receptors could be a therapeutic option for HER2-positive breast cancers. Here, we report that degradation of an endosomal small GTPase, RhoB, by the ubiquitin ligase complex cullin-3 (CUL3)/KCTD10 is essential for both EGFR and HER2 phosphorylation in HER2-positive breast cancer cells. Using human protein arrays produced in a wheat cell-free protein synthesis system, RhoB-GTP, and protein tyrosine phosphatase receptor type H (PTPRH) were identified as interacting proteins of connector enhancer of kinase suppressor of Ras1 (CNKSR1). Mechanistically, constitutive degradation of RhoB, which is mediated by the CUL3/KCTD10 E3 complex, enabled CNKSR1 to interact with PTPRH at the plasma membrane resulting in inactivation of EGFR phosphatase activity. Depletion of CUL3 or KCTD10 led to the accumulation of RhoB-GTP at the plasma membrane followed by its interaction with CNKSR1, which released activated PTPRH from CNKSR1. This study suggests a mechanism of PTPRH activation through the exclusive binding of RhoB-GTP to CNKSR1.
UR - http://www.scopus.com/inward/record.url?scp=85109603636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109603636&partnerID=8YFLogxK
U2 - 10.26508/LSA.202101095
DO - 10.26508/LSA.202101095
M3 - Article
C2 - 34187934
AN - SCOPUS:85109603636
SN - 2575-1077
VL - 4
JO - Life Science Alliance
JF - Life Science Alliance
IS - 9
M1 - e202101095
ER -